Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review)

References

• Aarts PA, van den Broek SA, Prins GW, Kuiken GD, Sixma JJ, Heethaar RM. 1988. Blood platelets are concentrated near the wall, red blood cells, in the center in flowing blood. Arteriosclerosis 8:819–824.
   PubMedGoogle Scholar
• Abbitt KB, Nash GB. 2003. Rheological properties of the blood influencing selectin-mediated adhesion of flowing leukocytes. Am J Physiol Heart Circ Physiol 285:H229–240.
   Google Scholar
• Acharya G, Shin CS, McDermott M, Mishra H, Park H, Kwon IC, Park K. 2010. The hydrogel template method for fabrication of homogeneous nano/microparticles. J Control Release 141:314–319.
   PubMed Web of Science ®Google Scholar
• Agashe HB, Dutta T, Garg M, Jain NK. 2006. Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer. J Pharm Pharmacol 58:1491–1498.
   PubMed Web of Science ®Google Scholar
• Akinc A, Thomas M, Klibanov AM, Langer R. 2005. Exploring polyethylenimine-mediated DNA transfection, the proton sponge hypothesis. J Gene Med 7:657–663.
   PubMed Web of Science ®Google Scholar
• Alexis F, Pridgen E, Molnar LK, Farokhzad OC. 2008. Factors affecting the clearance, biodistribution of polymeric nanoparticles. Mol Pharm 5:505–15.
   PubMed Web of Science ®Google Scholar
• Alyaudtin RN, Reichel A, Lobenberg R, Ramge P, Kreuter J, Begley DJ. 2001. Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo, in vitro. J Drug Target 9:209–221.
   PubMed Web of Science ®Google Scholar
• Anglin EJ, Cheng L, Freeman WR, Sailor MJ. 2008. Porous silicon in drug delivery devices, materials. Adv Drug Deliv Rev 60:1266–1277.
   PubMed Web of Science ®Google Scholar
• Backer MV, Gaynutdinov TI, Patel V, Bandyopadhyaya AK, Thirumamagal BT, Tjarks W, Barth RF, Claffey K, Backer JM. 2005. Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature. Mol Cancer Ther 4:1423–1429.
   PubMed Web of Science ®Google Scholar
• Bareford LM, Swaan PW. 2007. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 59:748–758.
   PubMed Web of Science ®Google Scholar
• Bermejo JF, Ortega P, Chonco L, Eritja R, Samaniego R, Mullner M, de Jesus E, de la Mata FJ, Flores JC, Gomez R, Munoz-Fernandez A. 2007. Water-soluble carbosilane dendrimers: synthesis biocompatibility, complexation with oligonucleotides; evaluation for medical applications. Chemistry 13:483–495.
   PubMed Web of Science ®Google Scholar
• Bhaskar S, Hitt J, Chang SW, Lahann J. 2009. Multicompartmental microcylinders. Angew Chem Int Ed Engl 48:4589–4593.
   PubMed Web of Science ®Google Scholar
• Bihari P, Holzer M, Praetner M, Fent J, Lerchenberger M, Reichel CA, Rehberg M, Lakatos S, Krombach F. 2009. Single-walled carbon nanotubes activate platelets, accelerate thrombus formation in the microcirculation. Toxicology 269:148–154.
   PubMedGoogle Scholar
• Bogdanov AA, Jr., Lin CP, Kang HW. 2007. Optical imaging of the adoptive transfer of human endothelial cells in mice using anti-human CD31 monoclonal antibody. Pharm Res 24:1186–1192.
   PubMedGoogle Scholar
• Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP. 1995. A versatile vector for gene, oligonucleotide transfer into cells in culture, in vivo: polyethylenimine. Proc Natl Acad Sci USA 92:7297–7301.
   PubMed Web of Science ®Google Scholar
• Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. 2001. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area, oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 175:191–199.
   PubMed Web of Science ®Google Scholar
• Buehler PW, Vallelian F, Mikolajczyk MG, Schoedon G, Schweizer T, Alayash AI, Schaer DJ. 2008. Structural stabilization in tetrameric or polymeric hemoglobin determines its interaction with endogenous antioxidant scavenger pathways. Antioxid Redox Signal 10:1449–1462.
   PubMed Web of Science ®Google Scholar
• Byrne JD, Betancourt T, Brannon-Peppas L. 2008. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 60:1615–1626.
   PubMed Web of Science ®Google Scholar
• Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, Dawson KA, Linse S. 2007. Understanding the nanoparticle-protein corona using methods to quantify exchange rates, affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 104:2050–2055.
   PubMed Web of Science ®Google Scholar
• Champion JA, Katare YK, Mitragotri S. 2007. Making polymeric micro-, nanoparticles of complex shapes. Proc Natl Acad Sci USA 104:11901–11904.
   PubMed Web of Science ®Google Scholar
• Champion JA, Mitragotri S. 2006. Role of target geometry in phagocytosis. Proc Natl Acad Sci USA 103:4930–4934.
   PubMed Web of Science ®Google Scholar
• Chan JM, Zhang L, Tong R, Ghosh D, Gao W, Liao G, Yuet KP, Gray D, Rhee JW, Cheng J, Golomb G, Libby P, Langer R, Farokhzad OC. 2010. Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Proc Natl Acad Sci USA 107:2213–2218.
   PubMedGoogle Scholar
• Charoenphol P, Huang RB, Eniola-Adefeso O. 2010. Potential role of size, hemodynamics in the efficacy of vascular-targeted spherical drug carriers. Biomaterials 31:1392–1402.
   PubMed Web of Science ®Google Scholar
• Chen B, Pogue BW, Hoopes PJ, Hasan T. 2006. Vascular, cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr 16:279–305.
   PubMed Web of Science ®Google Scholar
• Cheng Y, A CS, Meyers JD, Panagopoulos I, Fei B, Burda C. 2008. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J Am Chem Soc 130:10643–10647.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Samia AC, Li J, Kenney ME, Resnick A, Burda C. 2009. Delivery, efficacy of a cancer drug as a function of the bond to the gold nanoparticle surface. Langmuir 26:2248–2255.
   Google Scholar
• Chithrani BD, Ghazani AA, Chan WC. 2006. Determining the size, shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662–668.
   PubMed Web of Science ®Google Scholar
• Cho Y, Shi R, Borgens RB, Ivanisevic A. 2008. Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death. Nanomedicine 3:507–519.
   PubMed Web of Science ®Google Scholar
• Chouly C, Bordenave L, Bareille R, Guerin V, Baquey A, Pouliquen D, Baquey C, Jallet P. 1994. In vitro study of the hemocompatibility of superparamagnetic contrast agent for magnetic resonance imaging. Clin Mater 15:293–301.
   PubMedGoogle Scholar
• Coleman L. 2008. Nutrition, rheumatic disease (nutrition, health). Totowa, NJ: Humana Press.
   Google Scholar
• Cotter MJ, Muruve DA. 2005. The induction of inflammation by adenovirus vectors used for gene therapy. Front Biosci 10:1098–1105.
   PubMed Web of Science ®Google Scholar
• Davi G, Patrono C. 2007. Platelet activation, atherothrombosis. N Engl J Med 357:2482–2494.
   PubMed Web of Science ®Google Scholar
• Decuzzi P, Godin B, Tanaka T, Lee SY, Chiappini C, Liu X, Ferrari M. 2010. Size, shape effects in the biodistribution of intravascularly injected particles. J Control Release 141:320–327.
   PubMed Web of Science ®Google Scholar
• Decuzzi P, Pasqualini R, Arap W, Ferrari M. 2009. Intravascular delivery of particulate systems: does geometry really matter? Pharm Res 26:235–243.
   PubMed Web of Science ®Google Scholar
• Demos SM, Alkan-Onyuksel H, Kane BJ, Ramani K, Nagaraj A, Greene R, Klegerman M, McPherson DD. 1999. In vivo targeting of acoustically reflective liposomes for intravascular, transvascular ultrasonic enhancement. J Am Coll Cardiol 33:867–875.
   PubMed Web of Science ®Google Scholar
• Dhanikula RS, Argaw A, Bouchard JF, Hildgen P. 2008. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy, intratumoral transport capability. Mol Pharm 5:105–116.
   PubMed Web of Science ®Google Scholar
• Dhar S, Liu Z, Thomale J, Dai H, Lippard SJ. 2008. Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. J Am Chem Soc 130:11467–11476.
   PubMed Web of Science ®Google Scholar
• Diebold Y, Jarrin M, Saez V, Carvalho EL, Orea M, Calonge M, Seijo B, Alonso MJ. 2007. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP. Biomaterials 28:1553–1564.
   PubMed Web of Science ®Google Scholar
• Discher BM, Won YY, Ege DS, Lee JC, Bates FS, Discher DE, Hammer DA. 1999. Polymersomes: tough vesicles made from diblock copolymers. Science 284:1143–1146.
   PubMed Web of Science ®Google Scholar
• Domanski DM, Klajnert B, Bryszewska M. 2004. Influence of PAMAM dendrimers on human red blood cells. Bioelectrochemistry 63:189–191.
   PubMed Web of Science ®Google Scholar
• Dos Santos N, Allen C, Doppen AM, Anantha M, Cox KA, Gallagher RC, Karlsson G, Edwards K, Kenner G, Samuels L, Webb MS, Bally MB. 2007. Influence of poly(ethylene glycol) grafting density, polymer length on liposomes: relating plasma circulation lifetimes to protein binding. Biochim Biophys Acta 1768:1367–1377.
   PubMed Web of Science ®Google Scholar
• Dziubla TD, Shuvaev VV, Hong NK, Hawkins BJ, Madesh M, Takano H, Simone E, Nakada MT, Fisher A, Albelda SM, Muzykantov VR. 2008. Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies. Biomaterials 29:215–227.
   PubMed Web of Science ®Google Scholar
• Eckstein EC, Tilles AW, Millero FJ, 3rd. 1988. Conditions for the occurrence of large near-wall excesses of small particles during blood flow. Microvasc Res 36:31–39.
   PubMedGoogle Scholar
• Einav S, Bluestein D. 2004. Dynamics of blood flow, platelet transport in pathological vessels. Ann N Y Acad Sci 1015:351–366.
   PubMed Web of Science ®Google Scholar
• Eniola AO, Krasik EF, Smith LA, Song G, Hammer DA. 2005. I-domain of lymphocyte function-associated antigen-1 mediates rolling of polystyrene particles on ICAM-1 under flow. Biophys J 89:3577–3588.
   PubMedGoogle Scholar
• Eniola AO, Rodgers SD, Hammer DA. 2002. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes. Biomaterials 23:2167–2177.
   PubMed Web of Science ®Google Scholar
• Everts M, Schraa A, de Leij L, Meijer D, Molema G. 2001. Vascular endothelium in inflamed tissue as a target for site selective delivery of drugs. In: Molema G (ed.) Drug targeting: organ-specific strategies. Germany: Wiley-VCH.
   Google Scholar
• Fang C, Shi B, Pei YY, Hong MH, Wu J, Chen HZ. 2006. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight, particle size. Eur J Pharm Sci 27:27–36.
   PubMed Web of Science ®Google Scholar
• Fenart L, Casanova A, Dehouck B, Duhem C, Slupek S, Cecchelli R, Betbeder D. 1999. Evaluation of effect of charge, lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. J Pharmacol Exp Ther 291:1017–1022.
   PubMed Web of Science ®Google Scholar
• Gaspard J, Hahn MS, Silas JA. 2009. Polymerization of hydrogels inside self-assembled block copolymer vesicles. Langmuir 25:12878–12884.
   PubMedGoogle Scholar
• Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, Minko T, Discher DE. 2007. Shape effects of filaments versus spherical particles in flow, drug delivery. Nat Nanotechnol 2:249–255.
   PubMed Web of Science ®Google Scholar
• Gentile F, Curcio A, Indolfi C, Ferrari M, Decuzzi P. 2008. The margination propensity of spherical particles for vascular targeting in the microcirculation. J Nanobiotechnology 6:9.
   PubMedGoogle Scholar
• Gillies ER, Frechet JM. 2005. Dendrimers, dendritic polymers in drug delivery. Drug Discov Today 10:35–43.
   PubMed Web of Science ®Google Scholar
• Gimbrone MA, Jr., Topper JN, Nagel T, erson KR, Garcia-Cardena G. 2000. Endothelial dysfunction, hemodynamic forces, atherogenesis. Ann NY Acad Sci 902:230–239; discussion 9–40.
   PubMed Web of Science ®Google Scholar
• Gordon AN, Fleagle JT, Guthrie D, Parkin DE, Gore ME, Lacave AJ. 2001. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. J Clin Oncol 19:3312–3322.
   PubMed Web of Science ®Google Scholar
• Gosk S, Moos T, Gottstein C, Bendas G. 2008. VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. Biochim Biophys Acta 1778:854–863.
   PubMed Web of Science ®Google Scholar
• Gratton SE, Pohlhaus PD, Lee J, Guo J, Cho MJ, Desimone JM. 2007. Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles. J Control Release 121:10–18.
   PubMed Web of Science ®Google Scholar
• Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM. 2008. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA 105:11613–11618.
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Lee KJ, Kalishwaralal K, Sheikpranbabu S, Vaidyanathan R, Eom SH. 2009. Antiangiogenic properties of silver nanoparticles. Biomaterials 30:6341–6350.
   PubMed Web of Science ®Google Scholar
• Hajitou A, Pasqualini R, Arap W. 2006. Vascular targeting: recent advances, therapeutic perspectives. Trends Cardiovasc Med 16:80–88.
   PubMed Web of Science ®Google Scholar
• Harush-Frenkel O, Rozentur E, Benita S, Altschuler Y. 2008. Surface charge of nanoparticles determines their endocytic, transcytotic pathway in polarized MDCK cells. Biomacromolecules 9:435–443.
   PubMed Web of Science ®Google Scholar
• He Q, Zhang J, Shi J, Zhu Z, Zhang L, Bu W, Guo L, Chen Y. 2010. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins, cellular responses. Biomaterials 31:1085–1092.
   PubMed Web of Science ®Google Scholar
• He XW, Liu T, Xiao Y, Feng YL, Cheng DJ, Tingting G, Zhang L, Zhang Y, Chen YX. 2009. Vascular endothelial growth factor-C siRNA delivered via calcium carbonate nanoparticle effectively inhibits lymphangiogenesis, growth of colorectal cancer in vivo. Cancer Biother Radiopharm 24:249–259.
   PubMedGoogle Scholar
• Heslinga MJ, Mastria EM, Eniola-Adefeso O. 2009. Fabrication of biodegradable spheroidal microparticles for drug delivery applications. J Control Release 138:235–242.
   PubMed Web of Science ®Google Scholar
• Higginbotham JN, Seth P, Blaese RM, Ramsey WJ. 2002. The release of inflammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants, capsid. Hum Gene Ther 13:129–141.
   PubMed Web of Science ®Google Scholar
• Hoffman GS, Weyand CM. 2002. Inflammatory disease of blood vessels New York, NY: Marcel Dekker.
   Google Scholar
• Hong S, Leroueil PR, Majoros IJ, Orr BG, Baker JR, Jr., Banaszak Holl MM. 2007. The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol 14:107–115.
   PubMed Web of Science ®Google Scholar
• Hsu SH, Tang CM, Tseng HJ. 2006. Biocompatibility of poly(ether)urethane-gold nanocomposites. J Biomed Mater Res A 79:759–770.
   PubMed Web of Science ®Google Scholar
• Jallouli Y, Paillard A, Chang J, Sevin E, Betbeder D. 2007. Influence of surface charge, inner composition of porous nanoparticles to cross blood-brain barrier in vitro. Int J Pharm 344:103–109.
   PubMed Web of Science ®Google Scholar
• Jennings LK. 2009. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 102:248–257.
   PubMed Web of Science ®Google Scholar
• Jiang G, Park K, Kim J, Kim KS, Hahn SK. 2009. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis. Mol Pharm 6:727–737.
   PubMed Web of Science ®Google Scholar
• Jugdaohsingh R. 2007. Silicon, bone health. J Nutr Health Aging 11:99–110.
   PubMed Web of Science ®Google Scholar
• Kagan VE, Bayir H, Shvedova AA. 2005. Nanomedicine, nanotoxicology: two sides of the same coin. Nanomedicine 1:313–316.
   PubMed Web of Science ®Google Scholar
• Kaneda MM, Sasaki Y, Lanza GM, Milbrandt J, Wickline SA. 2010. Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions. Biomaterials 31:3079–3086.
   PubMedGoogle Scholar
• Kannan R, Navath R, Kurtoglu Y, Dai H, Wang B, Kannan S, Romero R. 2009. PAMAM dendrimers for brain delivery of therapeutics for the treatment of cerebral palsy: chemistry, in vivo efficacy, imaging. In: 61st AIChE Annual Meeting, 2009, Nashville, TN.
   Google Scholar
• Kaufmann BA, Sanders JM, Davis C, Xie A, Aldred P, Sarembock IJ, Lindner JR. 2007. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 116:276–284.
   PubMed Web of Science ®Google Scholar
• Kaul G, Amiji M. 2005. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro, in vivo studies. Pharm Res 22:951–961.
   PubMed Web of Science ®Google Scholar
• Ke W, Shao K, Huang R, Han L, Liu Y, Li J, Kuang Y, Ye L, Lou J, Jiang C. 2009. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. Biomaterials 30:6976–6985.
   PubMed Web of Science ®Google Scholar
• Kilpelainen M, Riikonen J, Vlasova MA, Huotari A, Lehto VP, Salonen J, Herzig KH, Jarvinen K. 2009. In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles. J Control Release 137:166–170.
   PubMed Web of Science ®Google Scholar
• Kim D, El-Shall H, Dennis D, Morey T. 2005. Interaction of PLGA nanoparticles with human blood constituents. Colloids Surf B Biointerfaces 40:83–91.
   PubMed Web of Science ®Google Scholar
• Kirkham M, Parton RG. 2005. Clathrin-independent endocytosis: new insights into caveolae, non-caveolar lipid raft carriers. Biochim Biophys Acta 1745:273–286.
   PubMed Web of Science ®Google Scholar
• Koudelka KJ, Destito G, Plummer EM, Trauger SA, Siuzdak G, Manchester M. 2009. Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin. PLoS Pathog 5:e1000417.
   Google Scholar
• Koziara JM, Oh JJ, Akers WS, Ferraris SP, Mumper RJ. 2005. Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles. Pharm Res 22:1821–1828.
   PubMed Web of Science ®Google Scholar
• Kratzer I, Wernig K, Panzenboeck U, Bernhart E, Reicher H, Wronski R, Windisch M, Hammer A, Malle E, Zimmer A, Sattler W. 2007. Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake, transcytosis in an in vitro model of the blood-brain barrier. J Control Release 117:301–311.
   PubMed Web of Science ®Google Scholar
• Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R. 2002. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target 10:317–325.
   PubMed Web of Science ®Google Scholar
• Kyriakides TR, Cheung CY, Murthy N, Bornstein P, Stayton PS, Hoffman AS. 2002. pH-sensitive polymers that enhance intracellular drug delivery in vivo. J Control Release 78:295–303.
   PubMed Web of Science ®Google Scholar
• Lackey CA, Press OW, Hoffman AS, Stayton PS. 2002. A biomimetic pH-responsive polymer directs endosomal release, intracellular delivery of an endocytosed antibody complex. Bioconjug Chem 13:996–1001.
   PubMed Web of Science ®Google Scholar
• Langeggen H, Namork E, Johnson E, Hetland G. 2003. HUVEC take up opsonized zymosan particles, secrete cytokines IL-6, IL-8 in vitro. FEMS Immunol Med Microbiol 36:55–61.
   PubMedGoogle Scholar
• Lee SY, Ferrari M, Decuzzi P. 2009. Design of bio-mimetic particles with enhanced vascular interaction. J Biomech 42:1885–1890.
   PubMed Web of Science ®Google Scholar
• Lee SY, Ferrari M, Decuzzi P. 2009. Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology 20:495101.
   PubMed Web of Science ®Google Scholar
• Lewinski N, Colvin V, Drezek R. 2008. Cytotoxicity of nanoparticles. Small 4:26–49.
   PubMed Web of Science ®Google Scholar
• Li SD, Chen YC, Hackett MJ, Huang L. 2008. Tumor-targeted delivery of siRNA by self-assembled nanoparticles. Mol Ther 16:163–169.
   PubMed Web of Science ®Google Scholar
• Li SD, Huang L. 2009. Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. Biochim Biophys Acta 1788:2259–2266.
   PubMed Web of Science ®Google Scholar
• Lim J, Guo Y, Rostollan CL, Stanfield J, Hsieh JT, Sun X, Simanek EE. 2008. The role of the size, number of polyethylene glycol chains in the biodistribution, tumor localization of triazine dendrimers. Mol Pharm 5:540–547.
   PubMed Web of Science ®Google Scholar
• Liu J, Jiang X, Ashley C, Brinker CJ. 2009. Electrostatically mediated liposome fusion, lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, delivery. J Am Chem Soc 131:7567–7569.
   PubMed Web of Science ®Google Scholar
• Ljubimova JY, Fujita M, Khazenzon NM, Lee BS, Wachsmann-Hogiu S, Farkas DL, Black KL, Holler E. 2008. Nanoconjugate based on polymalic acid for tumor targeting. Chem Biol Interact 171:195–203.
   PubMed Web of Science ®Google Scholar
• Lu W, Sun Q, Wan J, She Z, Jiang XG. 2006. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res 66:11878–11887.
   PubMed Web of Science ®Google Scholar
• Lu W, Tan YZ, Hu KL, Jiang XG. 2005. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability, little toxicity against blood-brain barrier. Int J Pharm 295:247–260.
   PubMed Web of Science ®Google Scholar
• Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. 2008. Nanoparticle size, surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105:14265–14270.
   PubMed Web of Science ®Google Scholar
• Manchester M, Singh P. 2006. Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging. Adv Drug Deliv Rev 58:1505–1522.
   PubMed Web of Science ®Google Scholar
• Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Frohlich E. 2009. The role of nanoparticle size in hemocompatibility. Toxicology 258:139–147.
   PubMed Web of Science ®Google Scholar
• Migliorini C, Qian Y, Chen H, Brown EB, Jain RK, Munn LL. 2002. Red blood cells augment leukocyte rolling in a virtual blood vessel. Biophys J 83:1834–1841.
   PubMed Web of Science ®Google Scholar
• Miyamoto M, Sasakawa S, Ozawa T, Kawaguchi H, Ohtsuka Y. 1989. Platelet aggregation induced by latex particles. I. Effects of size, surface potential, hydrophobicity of particles. Biomaterials 10:251–257.
   PubMedGoogle Scholar
• Movat HZ, Weiser WJ, Glynn MF, Mustard JF. 1965. Platelet phagocytosis, aggregation. J Cell Biol 27:531–543.
   PubMed Web of Science ®Google Scholar
• Munn LL, Melder RJ, Jain RK. 1996. Role of erythrocytes in leukocyte-endothelial interactions: mathematical model, experimental validation. Biophys J 71:466–478.
   PubMed Web of Science ®Google Scholar
• Muro S, Gajewski C, Koval M, Muzykantov VR. 2005. ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery, prolonged effects of drugs. Blood 105:650–658.
   PubMed Web of Science ®Google Scholar
• Muro S, Garnacho C, Champion JA, Leferovich J, Gajewski C, Schuchman EH, Mitragotri S, Muzykantov VR. 2008. Control of endothelial targeting, intracellular delivery of therapeutic enzymes by modulating the size, shape of ICAM-1-targeted carriers. Mol Ther 16:1450–1458.
   PubMed Web of Science ®Google Scholar
• Murphy EA, Majeti BK, Barnes LA, Makale M, Weis SM, Lutu-Fuga K, Wrasidlo W, Cheresh DA. 2008. Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proc Natl Acad Sci USA 105:9343–9348.
   PubMed Web of Science ®Google Scholar
• Muzykantov VR. 2001. Targeting of superoxide dismutase, catalase to vascular endothelium. J Control Release 71:1–21.
   PubMed Web of Science ®Google Scholar
• Nemmar A, Melghit K, Ali BH. 2008. The acute proinflammatory, prothrombotic effects of pulmonary exposure to rutile TiO2 nanorods in rats. Exp Biol Med (Maywood) 233:610–619.
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Iwakiri N, Kaneko Y, Taguchi A, Fukushima K, Mori H, Morone N, Kadokawa J. 2009. Nitric oxide release in human aortic endothelial cells mediated by delivery of amphiphilic polysiloxane nanoparticles to caveolae. Biomacromolecules 10:2074–2085.
   PubMed Web of Science ®Google Scholar
• Ondaral S, Wagberg L, Enarsson LE. 2006. The adsorption of hyperbranched polymers on silicon oxide surfaces. J Colloid Interface Sci 301:32–39.
   PubMedGoogle Scholar
• Pack DW, Putnam D, Langer R. 2000. Design of imidazole-containing endosomolytic biopolymers for gene delivery. Biotechnol Bioeng 67:217–223.
   PubMed Web of Science ®Google Scholar
• Pappu V, Bagchi P. 2007. Hydrodynamic interaction between erythrocytes, leukocytes affects rheology of blood in microvessels. Biorheology 44:191–215.
   PubMed Web of Science ®Google Scholar
• Park JH, Gu L, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ. 2009. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater 8:331–336.
   PubMed Web of Science ®Google Scholar
• Partlow KC, Lanza GM, Wickline SA. 2008. Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery. Biomaterials 29:3367–3375.
   PubMed Web of Science ®Google Scholar
• Patil Y, Sadhukha T, Ma L, Panyam J. 2009. Nanoparticle-mediated simultaneous, targeted delivery of paclitaxel, tariquidar overcomes tumor drug resistance. J Control Release 136:21–29.
   PubMed Web of Science ®Google Scholar
• Pearson MJ, Lipowsky HH. 2000. Influence of erythrocyte aggregation on leukocyte margination in postcapillary venules of rat mesentery. Am J Physiol Heart Circ Physiol 279:H1460–471.
   Google Scholar
• Pedro L, Soares SS, Ferreira GNM. 2008. Purification of bionanoparticles. Chem Eng Technol 31:815–825.
   Google Scholar
• Peters D, Kastantin M, Kotamraju VR, Karmali PP, Gujraty K, Tirrell M, Ruoslahti E. 2009. Targeting atherosclerosis by using modular, multifunctional micelles. Proc Natl Acad Sci USA 106:9815–9819.
   PubMed Web of Science ®Google Scholar
• Peters K, Unger RE, Kirkpatrick CJ, Gatti AM, Monari E. 2004. Effects of nano-scaled particles on endothelial cell function in vitro: studies on viability, proliferation, inflammation. J Mater Sci Mater Med 15:321–325.
   PubMed Web of Science ®Google Scholar
• Photos PJ, Bacakova L, Discher B, Bates FS, Discher DE. 2003. Polymer vesicles in vivo: correlations with PEG molecular weight. J Control Release 90:323–334.
   PubMed Web of Science ®Google Scholar
• Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T, Radomski MW. 2005. Nanoparticle-induced platelet aggregation, vascular thrombosis. Br J Pharmacol 146:882–893.
   PubMed Web of Science ®Google Scholar
• Reddy GR, Bhojani MS, McConville P, Moody J, Moffat BA, Hall DE, Kim G, Koo YE, Woolliscroft MJ, Sugai JV, Johnson TD, Philbert MA, Kopelman R, Rehemtulla A, Ross BD. 2006. Vascular targeted nanoparticles for imaging, treatment of brain tumors. Clin Cancer Res 12:6677–6686.
   PubMed Web of Science ®Google Scholar
• Rejman J, Bragonzi A, Conese M. 2005. Role of clathrin-, caveolae-mediated endocytosis in gene transfer mediated by lipo-, polyplexes. Mol Ther 12:468–474.
   PubMed Web of Science ®Google Scholar
• Rejman J, Oberle V, Zuhorn IS, Hoekstra D. 2004. Size-dependent internalization of particles via the pathways of clathrin-, caveolae-mediated endocytosis. Biochem J 377:159–169.
   PubMed Web of Science ®Google Scholar
• Rolland JP, Maynor BW, Euliss LE, Exner AE, Denison GM, DeSimone JM. 2005. Direct fabrication, harvesting of monodisperse, shape-specific nanobiomaterials. J Am Chem Soc 127:10096–10100.
   PubMed Web of Science ®Google Scholar
• Ross JS, Stagliano NE, Donovan MJ, Breitbart RE, Ginsburg GS. 2001. Atherosclerosis, cancer: common molecular pathways of disease development, progression. Ann NY Acad Sci 947:271–292; discussion 292–3.
   PubMed Web of Science ®Google Scholar
• Sakhalkar HS, Dalal MK, Salem AK, Ansari R, Fu J, Kiani MF, Kurjiaka DT, Hanes J, Shakesheff KM, Goetz DJ. 2003. Leukocyte-inspired biodegradable particles that selectively, avidly adhere to inflamed endothelium in vitro, in vivo. Proc Natl Acad Sci USA 100:15895–15900.
   PubMed Web of Science ®Google Scholar
• Salonen J, Kaukonen AM, Hirvonen J, Lehto VP. 2008. Mesoporous silicon in drug delivery applications. J Pharm Sci 97:632–653.
   PubMed Web of Science ®Google Scholar
• Schwendener RA. 2007. Liposomes in biology, medicine. Adv Exp Med Biol 620:117–128.
   PubMed Web of Science ®Google Scholar
• Serda RE, Gu J, Bhavane RC, Liu X, Chiappini C, Decuzzi P, Ferrari M. 2009. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials 30:2440–2448.
   PubMed Web of Science ®Google Scholar
• Shcharbin D, Pedziwiatr E, Blasiak J, Bryszewska M. 2009. How to study dendriplexes II: transfection, cytotoxicity. J Control Release 141:110–127.
   PubMedGoogle Scholar
• Shi X, Wang S, Meshinchi S, Van Antwerp ME, Bi X, Lee I, Baker JR, Jr. 2007. Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting, imaging. Small 3:1245–1252.
   PubMed Web of Science ®Google Scholar
• Shrivastava S, Bera T, Singh SK, Singh G, Ramachandrarao P, Dash D. 2009. Characterization of antiplatelet properties of silver nanoparticles. ACS Nano 3:1357–1364.
   PubMed Web of Science ®Google Scholar
• Shriver LP, Koudelka KJ, Manchester M. 2009. Viral nanoparticles associate with regions of inflammation, blood brain barrier disruption during CNS infection. J Neuroimmunol 211:66–72.
   PubMed Web of Science ®Google Scholar
• Simone E, Ding BS, Muzykantov V. 2009. Targeted delivery of therapeutics to endothelium. Cell Tissue Res 335:283–300.
   PubMed Web of Science ®Google Scholar
• Simone EA, Dziubla TD, Discher DE, Muzykantov VR. 2009. Filamentous polymer nanocarriers of tunable stiffness that encapsulate the therapeutic enzyme catalase. Biomacromolecules 10:1324–1330.
   PubMed Web of Science ®Google Scholar
• Smith BR, Heverhagen J, Knopp M, Schmalbrock P, Shapiro J, Shiomi M, Moldovan NI, Ferrari M, Lee SC. 2007. Localization to atherosclerotic plaque, biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI). Biomed Microdevices 9:719–727.
   PubMed Web of Science ®Google Scholar
• Sonavane G, Tomoda K, Makino K. 2008. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces 66:274–280.
   PubMed Web of Science ®Google Scholar
• Sonawane ND, Szoka FC, Jr., Verkman AS. 2003. Chloride accumulation, swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem 278:4826–4831.
   PubMedGoogle Scholar
• Southworth R, Kaneda M, Chen J, Zhang L, Zhang H, Yang X, Razavi R, Lanza G, Wickline SA. 2009. Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons. Nanomedicine 5:359–367.
   PubMedGoogle Scholar
• Srinivasan R, Marchant RE, Gupta AS. 2009. In vitro, in vivo platelet targeting by cyclic RGD-modified liposomes. J Biomed Mater Res A 93:1004–1015.
   Google Scholar
• Stan RV. 2006. Endocytosis pathways in endothelium: how many? Am J Physiol Lung Cell Mol Physiol 290:L806–808.
   Google Scholar
• Stevens KN, Crespo-Biel O, van den Bosch EE, Dias AA, Knetsch ML, Aldenhoff YB, van der Veen FH, Maessen JG, Stobberingh EE, Koole LH. 2009. The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles, the coagulation of contacting blood. Biomaterials 30:3682–3690.
   PubMed Web of Science ®Google Scholar
• Strother R, Matei D. 2009. Pegylated liposomal doxorubicin in ovarian cancer. Ther Clin Risk Manag 5:639–650.
   PubMedGoogle Scholar
• Sutton D, Nasongkla N, Blanco E, Gao J. 2007. Functionalized micellar systems for cancer targeted drug delivery. Pharm Res 24:1029–1046.
   PubMed Web of Science ®Google Scholar
• Takeda M, Tada H, Higuchi H, Kobayashi Y, Kobayashi M, Sakurai Y, Ishida T, Ohuchi N. 2008. In vivo single molecular imaging, sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems, tailor-made medicine. Breast Cancer 15:145–52.
   PubMed Web of Science ®Google Scholar
• Tasciotti E, Liu X, Bhavane R, Plant K, Leonard AD, Price BK, Cheng MM, Decuzzi P, Tour JM, Robertson F, Ferrari M. 2008. Mesoporous silicon particles as a multistage delivery system for imaging, therapeutic applications. Nat Nanotechnol 3:151–157.
   PubMed Web of Science ®Google Scholar
• Traub LM. 2009. Tickets to ride: selecting cargo for clathrin-regulated internalization. Nat Rev Mol Cell Biol 10:583–596.
   PubMed Web of Science ®Google Scholar
• Uyar D, Kulp B, Peterson G, Zanotti K, Markman M, Belinson J. 2004. Cardiac safety profile of prolonged (≥6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies. Gynecol Oncol 94:147–151.
   PubMed Web of Science ®Google Scholar
• Vargas A, Eid M, Fanchaouy M, Gurny R, Delie F. 2008. In vivo photodynamic activity of photosensitizer-loaded nanoparticles: formulation properties, administration parameters, biological issues involved in PDT outcome. Eur J Pharm Biopharm 69:43–53.
   PubMed Web of Science ®Google Scholar
• Voinea M, Manduteanu I, Dragomir E, Capraru M, Simionescu M. 2005. Immunoliposomes directed toward VCAM-1 interact specifically with activated endothelial cells – a potential tool for specific drug delivery. Pharm Res 22:1906–1917.
   PubMed Web of Science ®Google Scholar
• Wagner DD, Frenette PS. 2008. The vessel wall, its interactions. Blood 111:5271–5281.
   PubMed Web of Science ®Google Scholar
• Wang P, Xue Y, Shang X, Liu Y. 2009. Diphtheria toxin mutant CRM197-mediated transcytosis across blood-brain barrier in vitro. Cell Mol Neurobiol 30:717–725.
   Google Scholar
• Wilhelm C, Bal L, Smirnov P, Galy-Fauroux I, Clement O, Gazeau F, Emmerich J. 2007. Magnetic control of vascular network formation with magnetically labeled endothelial progenitor cells. Biomaterials 28:3797–3806.
   PubMed Web of Science ®Google Scholar
• Winter PM, Neubauer AM, Caruthers SD, Harris TD, Robertson JD, Williams TA, Schmieder AH, Hu G, Allen JS, Lacy EK, Zhang H, Wickline SA, Lanza GM. 2006. Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol 26:2103–2109.
   PubMed Web of Science ®Google Scholar
• Wiwanitkit V, Sereemaspun A, Rojanathanes R. 2009. Gold nanoparticles, a microscopic view of platelets: a preliminary observation. Cardiovasc J Afr 20:141–142.
   PubMedGoogle Scholar
• Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. 1995. Vascular permeability in a human tumor xenograft: molecular size dependence, cutoff size. Cancer Res 55:3752–3756.
   PubMed Web of Science ®Google Scholar
• Zensi A, Begley D, Pontikis C, Legros C, Mihoreanu L, Wagner S, Buchel C, von Briesen H, Kreuter J. 2009. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis, are delivered to neurones. J Control Release 137:78–86.
   PubMed Web of Science ®Google Scholar
• Zhang N, Chittasupho C, Duangrat C, Siahaan TJ, Berkland C. 2008. PLGA nanoparticle–peptide conjugate effectively targets intercellular cell-adhesion molecule-1. Bioconjug Chem 19:145–152.
   PubMed Web of Science ®Google Scholar
• Zhu J, Xue J, Guo Z, Zhang L, Marchant RE. 2007. Biomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated platelets. Bioconjug Chem 18:1366–1369.
   PubMed Web of Science ®Google Scholar